Daniel Jones

1.2k citations

22 papers · 468 indexed · h-index 9

Impact in

Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Estrogen and related hormone effects
Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment

Papers in

Health Informatics 1
Genetics 7
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2

Co-authors: Richard T. Pickard Robert J. Schmidt Patrick I. Eacho Patricia Foxworthy Kieron Dunleavy Wyndham H. Wilson Sin‐Ho Jung Pierluigi Porcu
Journals: Journal of Cellular Biochemistry (2 papers)Haematologica (2 papers)Blood (2 papers)Postgraduate Medical Journal (1 paper)Critical Reviews in Eukaryotic Gene Expression (1 paper)
Partner nations: United States United Kingdom Spain

In The Last Decade

Daniel Jones

21 papers receiving 458 citations

Peers

Countries citing papers authored by Daniel Jones

Since Specialization

Citations

This map shows the geographic impact of Daniel Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Jones more than expected).

Fields of papers citing papers by Daniel Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Jones. The network helps show where Daniel Jones may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Jones Line = papers co-authored together Daniel Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Novel Bayesian General Medical Diagnostic Assistant Achieves Superior Accuracy With Sparse History Frontiers in Artificial Intelligence ·Оксана Григорівна Гаврилюк, Daniel Jones	2022	2
2	FISH Analysis of CDKN2A/B Deletion in Chronic Lymphocytic Leukemia Blood ·Jaclyn Green, Singh Ruchi, Adam S. Kittai, Seema A. Bhat, Michael R. Grever, Kerry A. Rogers, Weiqiang Zhao, Daniel Jones, John C. Byrd, Matthew R. Avenarius, Nyla A. Heerema, Jennifer A. Woyach, Cecelia Miller	2022	2
3	Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia Haematologica ·Kerry A. Rogers, Philip A. Thompson, John N. Allan, Morton Coleman, Jeff P. Sharman, Bruce D. Cheson, Daniel Jones, Raquel Izumi, Melanie M. Frigault, Cheng S. Quah, Alexandru Oltean-Cîmpean, Priti Patel, Min Hui Wang, Thomas J. Kipps	2021	76
4	Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation Transplantation and Cellular Therapy ·Evan C. Chen, Shuli Li, Ann-Kathrin Eisfeld, Marlise R. Luskin, Alice S. Mims, Daniel Jones, Joseph H. Antin, Corey Cutler, John Koreth, Vincent T. Ho, Mahasweta Gooptu, Rizwan Romee, Areej El‐Jawahri, Steven L. McAfee, Zachariah DeFilipp, Robert J. Soiffer, Yi‐Bin Chen, Amir T. Fathi	2021	10
5	Type of prior genotoxic insult determines the genomic characteristics of therapy‐related myeloid neoplasms American Journal of Hematology ·宏文柴井, James S. Blachly, Ann‐Kathrin Eisfeld, Nicole R. Grieselhuber, Karilyn Larkin, Alison Walker, Bhavana Bhatnagar, Gregory K. Behbehani, Meixiao Long, 강성철, Sumithira Vasu, Weiqiang Zhao, Daniel Jones, John C. Byrd, Alice S. Mims, Caner Saygin	2021	2
6	Rarity of B-Cell Receptor Pathway Mutations in Progression-Free Patients With Chronic Lymphocytic Leukemia (CLL) During First-Line Versus Relapsed/Refractory (R/R) Treatment With Ibrutinib Blood ·Adrian Wiestner, Paolo Ghia, John C. Byrd, Inhye E. Ahn, Carol Moreno, Susan O’Brien, Daniel Jones, Leo W.K. Cheung, Elizabeth Chong, Kevin Kwei, James P. Dean, Danelle F. James, Jennifer A. Woyach	2020	6
7	PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment Leukemia ·Daniel Jones, Jennifer A. Woyach, Weiqiang Zhao, Abdollah Mohammadi, Huolin Tu, 洋一文字, John C. Byrd, Amy J. Johnson, Gerard Lozanski	2017	49
8	Death effects of reveromycin A in normal and disease‐associated cells of the joint Journal of Cellular Biochemistry ·Shinta Komalasari, Matthieu Sacrez, Silvia Parrabera-García, Shunsuke Okahata, Pascale SURINI, Smrthi Harits, AE Sijuwola, Dania Prieto Prueba, Magdalena Utsch, Gabriela Allein, Beatriz Bezerra Tone, Clemilson Xavier de Oliveira, 曹海龙, Ja Hwan Kim, Mark A. Lipton, Daniel Jones	2017	6
9	Reveromycin A‐Induced Apoptosis in Osteoclasts Is Not Accompanied by Necrosis Journal of Cellular Biochemistry ·Antonia María Sánchez, Birda Mudafiuddin, Joey A. Mitchell, Yang Hyun M, Ernesto Betancourt Andino, Shruti Gupta, Stoyan Prodanov, О. О. Морковін, Jemma Grindstaff, Xinjin Guo, C. Wetzei, Prinson Dsouza, David Collins, M Bossuyt Patrick, Z. K. Jia, Daniel Jones	2015	2
10	A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling. PubMed ·Daniel Jones	2015	7
11	Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia ( BCR-ABL1 ⁺ ) Archives of Pathology & Laboratory Medicine ·Todd W. Kelley, Daniel A. Arber, Christine Gibson, Daniel Jones, Joseph D. Khoury, Bruno C. Medeiros, Dennis P. O’Malley, Keyur P. Patel, Monika Pilichowska, Mohammad A. Vasef, 英利藤原, James L. Zehnder	2015	1
12	A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype Haematologica ·Wyndham H. Wilson, Sin‐Ho Jung, Pierluigi Porcu, David D. Hurd, Jeffrey L. Johnson, Scott E. Martin, M. S. Czuczman, Raymond Lai, Jonathan Said, Amy Chadburn, Daniel Jones, Kieron Dunleavy, George P. Canellos, Andrew D. Zelenetz, Bruce D. Cheson, Eric D. Hsi, (unknown)	2011	125
13	Stage IB Nonsmall Cell Lung Cancers: Are They All the Same? Yearbook of Surgery ·Daniel Jones	2007	1
14	Failed Antireflux Surgery: Results After Reoperation Yearbook of Surgery ·Daniel Jones	2007	0
15	Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts American Journal of Physiology-Endocrinology and Metabolism ·富次阿部, Marta Alvarez, Daniel Jones, Kitti Torrungruang, Andrew Watt, N. Selvamurugan, Nicola C. Partridge, Cheryl O. Quinn, L L Chen, Simon J. Rhodes, Joseph P. Bidwell	2004	37
16	Estrogen receptor-mediated repression of human hepatic lipase gene transcription Journal of Lipid Research ·Daniel Jones, Robert J. Schmidt, Richard T. Pickard, Patricia Foxworthy, Patrick I. Eacho	2002	79
17	Involvement of the Nuclear Matrix in the Control of Skeletal Genes: The NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) Transcription Factors Critical Reviews in Eukaryotic Gene Expression ·Joseph P. Bidwell, Kitti Torrungruang, Marta Alvarez, Simon J. Rhodes, 富次阿部, Daniel Jones, Riffat Naz Akhtar, Janet M. Hock, Andrew Watt	2001	25
18	A Bifunctional Regulatory Element of the Human ApoA-I Gene Responsive to a Distal Enhancer DNA and Cell Biology ·Daniel Jones, Michael Leffak	1999	4
19	Seroprevalence of Hepatitis B Virus among School-Age Children in the Stann Creek District of Belize, Central America American Journal of Tropical Medicine and Hygiene ·Judith Chamberlin, P. Spillantini, Daniel Jones, Daifemg Jiang, Shilpa Hakre	1996	6
20	Assessment of British Gammaglobulin in Preventing Infectious Hepatitis BMJ ·Yvonne E. Cossart, Elizabeth Gillespie, Daniel Jones, Janet Kelsey, Brian Moore, Iain R. Murray, Sheila Polakoff, G. Turner, Mokshagna Rohit Gangavarapu, 洋一文字, Ragıp Atakan Al, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1968	17

About Daniel Jones

Daniel Jones is a scholar working on Health Informatics, Genetics, Family Practice, Hematology and Hepatology, having authored 22 papers that have together received 468 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (3 papers), Hepatitis B Virus Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Bone Metabolism and Diseases (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), TGF-β signaling in diseases (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (178 citations), Pathology and Forensic Medicine (220 citations), Hematology (64 citations), Oncology (114 citations) and Immunology (63 citations). Daniel Jones has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Richard T. Pickard, Robert J. Schmidt, Patrick I. Eacho, Patricia Foxworthy, Kieron Dunleavy, Wyndham H. Wilson, Sin‐Ho Jung, Pierluigi Porcu, David D. Hurd and Scott E. Martin. Their work appears in journals such as Journal of Cellular Biochemistry, Haematologica, Blood, Postgraduate Medical Journal and Critical Reviews in Eukaryotic Gene Expression.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact